Important topics at ESMO 2017
Phase 2 trial of chemotherapy plus gefitinib as first-line treatment for lung adenocarcinoma
Mesothelioma surgical trial updates in the UK: MARS2 and MesoTRAP
Avelumab and pembrolizumab for the treatment of merkel cell carcinoma
Sandra D'Angelo et al.
Issues with pharmaceutical research funding
Wim van Harten